Clinical trial
Pain Medication Tapering for Patients With Persistent Spinal Pain Syndrome Type 2, Treated With Spinal Cord Stimulation.
NCT05861609 is registered in ClinicalTrials.gov with Moens Maarten as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pain Medication Tapering for Patients With Persistent Spinal Pain Syndrome Type 2, Treated With Spinal Cord Stimulation.
- Lead sponsor
- Moens Maarten
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 29, 2023
- Completion date
- September 30, 2026
- Enrollment
- 195 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
persistent spinal pain syndrome type 2, spinal cord stimulation